Linganisha mbinu

	Kiwango cha Tathmini ya Ugonjwa wa Alzheimer-Cognitive	Betri ya Tathmini ya Mbele
Nyanja	Neurosaikolojia	Neurosaikolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	1984	2000
Mwanzilishi	William Rosen	Bruno Dubois
Aina	Clinician-administered cognitive scale for Alzheimer's disease	Clinician-administered neuropsychological battery for frontal lobe function
Chanzo asilia	Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141(11), 1356-1364.	Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A Frontal Assessment Battery at bedside. Neurology, 55(11), 1621-1626.
Majina mbadala	ADAS-Cog, ADAS-Cog14, ADAS-Cog13	FAB, Frontal Battery
Zinazohusiana	5	5
Muhtasari	The Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) is a clinician-administered cognitive assessment instrument designed specifically to measure cognitive decline in Alzheimer's disease. Developed by Rosen, Mohs, and Davis in 1984 and published in the American Journal of Psychiatry, the ADAS-Cog has become the gold standard outcome measure in pharmaceutical trials of antidementia drugs. It is sensitive to disease progression and capable of detecting cognitive change over periods as brief as 6–12 months.	The Frontal Assessment Battery (FAB) is a brief, clinician-administered neuropsychological battery designed to assess frontal lobe function and executive abilities at the bedside. Developed by Dubois and colleagues at the Salpêtrière Hospital in Paris in 2000, the FAB consists of six subtests measuring conceptualization, mental flexibility, motor planning, inhibitory control, and verbal fluency. The FAB is particularly sensitive to frontotemporal dementia, Parkinson's disease with cognitive decline, and other conditions affecting prefrontal function.